Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Fresh from the Pipeline
  • Published:

Inhaled human insulin

Nature Reviews Drug Discovery volume 5, pages 371–372 (2006)Cite this article

Abstract

In January 2006, human insulin inhalation powder (Exubera; Pfizer) was approved by the US FDA and the EMEA for the treatment of adult patients with diabetes mellitus. It is the first non-injectable insulin to be approved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Leahy, J. L & Cefalu, W. T. (eds). Insulin Therapy (Marcel Dekker, New York, 2002).

    Book  Google Scholar 

  2. Owens, D. R. New horizons — alternative routes for insulin therapy. Nature Rev. Drug Discov. 1, 529–540 (2002).

    Article  CAS  Google Scholar 

  3. White, S. et al. Exubera: pharmaceutical development of novel product for pulmonary delivery of insulin. Diabetes Technol. Ther. 7, 896–906 (2005).

    Article  CAS  Google Scholar 

  4. Quattrin, T. et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 27, 2622–2627 (2004).

    Article  CAS  Google Scholar 

  5. FDA labelling information [online], (2006).

  6. DeFronzo, R. A. et al. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care 27, 1922–1928 (2005).

    Article  Google Scholar 

  7. Hollander, P. A. et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 27, 2356–2362 (2004).

    Article  CAS  Google Scholar 

  8. CHMP summary of opinion [online], (2005).

  9. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287, 2563–2569 (2002).

  10. Stratton, I. M. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405–412 (2000).

    Article  CAS  Google Scholar 

  11. Saunders, S. A. et al. Glycaemic control in a type 1 diabetes clinic for younger adults. QJM 97, 575–580 (2004).

    Article  CAS  Google Scholar 

  12. Brown, J. B. et al. The burden of treatment failure in type 2 diabetes. Diabetes Care 27, 1535–1540 (2004).

    Article  Google Scholar 

  13. Peyrot, M. et al. Resistance to insulin therapy among patients and providers. Diabetes Care 28, 2673–2679, (2005).

  14. Rosenstock, J. et al. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care 27, 1318–1323 (2004).

    Article  Google Scholar 

  15. International Diabetes Federation, <http://www.idf.org>.

  16. WHO, <http://www.who.int/diabetes>.

  17. IMS Health, IMS MIDAS Quantum, MAT (Dec 2005).

Download references

Author information

Authors and Affiliations

  1. the Diabetes Research Unit, Llandough Hospital, University of Wales College of Medicine, Cardiff, CF64 2XX, Wales, UK

    David R. Owens

  2. IMS Health, 7 Harewood Avenue, London, NW1 6JB, UK

    Joanne Grimley

  3. Nature Reviews Drug Discovery,

    Peter Kirkpatrick

Authors
  1. David R. Owens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanne Grimley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Kirkpatrick
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Owens, D., Grimley, J. & Kirkpatrick, P. Inhaled human insulin. Nat Rev Drug Discov 5, 371–372 (2006). https://doi.org/10.1038/nrd2052

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2052

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing